Friday, March 14, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

931 POSTS 0 COMMENTS
All News

StHealth Capital, Our #1 Ranked Emerging BDC Idea.

Editor / Curator -
video
Video

StHealth Private Equity Medtech Fund. Alternative Investment BDC.

Editor / Curator -
DIABASENS
All News

Diabasens® to Launch in Europe. Innovus (INNV).

Editor / Curator -
BDC

Former Tesla Foundation Vice Chairman Joins StHealth BDC.

Editor / Curator -
Biotech News

Hercules BDC (HTGC) $13, to Present at FB Riley.

Editor / Curator -
Biotech News

Innovus (INNV) in Silicon Review Interview.

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Transcript.

Editor / Curator -
Biotech News

Vaccinex (VCNX) Reports First Quarter 2019 Financial Results and Provides Corporate...

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

Editor / Curator -
biotech stock review, fluticare
All News

Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)

Editor / Curator -
1...838485...94Page 84 of 94

Latest article

And We Have a Trading Idea!

2025 Watch List Editor / Curator -
Adding Zomedica (ZOM, ZOMDF) $0.037 to Watch List. Our first 'publicly announced' trading idea, in what might be decades....

We’re Back! And We’re Adding (again), GeoVax (GOVX), the Alkaline Water Co (WTER) and...

2025 Watch List Editor / Curator -
GeoVax (GOVX) $1.64. Recent High $11.18 (BiotechStockReview) The Alkaline Water Co. (WTER) $0.09. Recent High $0.48 (BeverageStockReview)

Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

All News Editor / Curator -
119% Gain Post Split
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.